Research ArticleORIGINAL ARTICLE
The Nongenotropic Synthetic Ligand 4-Estren-3α17β-diol Is a High-Affinity Genotropic Androgen Receptor Agonist
V. Krishnan, H. A. Bullock, B. C. Yaden, M. Liu, R. J. Barr, C. Montrose-Rafizadeh, K. Chen, J. A. Dodge and H. U. Bryant
Molecular Pharmacology March 2005, 67 (3) 744-748; DOI: https://doi.org/10.1124/mol.104.005272
V. Krishnan
H. A. Bullock
B. C. Yaden
M. Liu
R. J. Barr
C. Montrose-Rafizadeh
K. Chen
J. A. Dodge
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleORIGINAL ARTICLE
The Nongenotropic Synthetic Ligand 4-Estren-3α17β-diol Is a High-Affinity Genotropic Androgen Receptor Agonist
V. Krishnan, H. A. Bullock, B. C. Yaden, M. Liu, R. J. Barr, C. Montrose-Rafizadeh, K. Chen, J. A. Dodge and H. U. Bryant
Molecular Pharmacology March 1, 2005, 67 (3) 744-748; DOI: https://doi.org/10.1124/mol.104.005272
Research ArticleORIGINAL ARTICLE
The Nongenotropic Synthetic Ligand 4-Estren-3α17β-diol Is a High-Affinity Genotropic Androgen Receptor Agonist
V. Krishnan, H. A. Bullock, B. C. Yaden, M. Liu, R. J. Barr, C. Montrose-Rafizadeh, K. Chen, J. A. Dodge and H. U. Bryant
Molecular Pharmacology March 1, 2005, 67 (3) 744-748; DOI: https://doi.org/10.1124/mol.104.005272
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement